10 November 2016 - Deborah Wilkes
Archived
Pfizer is evaluating a potential sale or spin-off for its Consumer Healthcare business, according to a Reuters news story. The report comes a few days after Pfizer's chairman and chief executive officer Ian Read said the pharmaceutical company continued to test all of its businesses, including Consumer Healthcare, to see if they were "worth more inside or outside of Pfizer".
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.